Objectives - discussion on the journal article:
1. Learn about tofacitinib and its role as a new therapy for ankylosing spondylitis (AS).
2. Analyze and review the journal article provided.
3. Discuss the clinical role of using tofacitinib in our patients with AS.
Session date:
12/19/2017 - 8:30am to 9:30am CST
Location:
UCMC
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Josna Haritha, M.D.